February 27, 2025
The US Food and Drug Administration (FDA) has accepted a supplemental New Drug Application for topical roflumilast, 0.05%, for the treatment of mild to moderate atopic […]
February 26, 2025
TOPLINE: In a retrospective cohort study, nicotinamide exposure showed no increased risk for MACE. Prior MACE history, however, was strongly associated with subsequent MACE. METHODOLOGY: To […]
February 25, 2025
Dermatologists are practicing in an “era of good efficacy” of nonsteroidal topical therapies for psoriasis, and they can help patients access newer topical medications by working […]
February 25, 2025
TOPLINE: A study found no significant association between pediatric vitiligo and visual acuity deficits, suggesting that routine vision screening may not be necessary for this population. […]
February 24, 2025
TOPLINE: A study showed that survivors of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) had an increased risk for cardiovascular morbidity and mortality, which peaked […]
February 21, 2025
The formulation of benzoyl peroxide (BP) products plays a role in the levels of benzene found, according to new research, with leave-on products found to have […]
February 20, 2025
Dupilumab has been accepted for priority review by the US Food and Drug Administration (FDA) for the treatment of bullous pemphigoid (BP) in adults, according to […]
February 19, 2025
TOPLINE: Mohs surgery was associated with improved outcomes compared with wide local excision (WLE) in patients with primary high-stage cutaneous squamous cell carcinoma (cSCC), showing lower […]
February 19, 2025
Why do we scratch? Scratching in response to itching is both pleasurable and harmful. In skin conditions, particularly dermatitis, scratching creates a vicious cycle, intensifying the […]